| 1 |
PMED: Optimal Bayesian Platform Trial Design with Multiple Endpoints |
|
|
| Tian He, Rachael Liu, Meizi Liu, Jianchang Lin |
|
| Journal of Biopharmaceutical Statistics. 2022; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Progress, development and challenges in amyotrophic lateral sclerosis clinical trials |
|
|
| Jasmine F. Ashhurst, Sicong Tu, Hannah C. Timmins, Matthew C. Kiernan |
|
| Expert Review of Neurotherapeutics. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Applications of artificial intelligence and machine learning in heart failure |
|
|
| Tauben Averbuch, Kristen Sullivan, Andrew Sauer, Mamas A Mamas, Adriaan A. Voors, Chris P. Gale, Marco Metra, Neal Ravindra, Harriette G.C. Van Spall |
|
| European Heart Journal - Digital Health. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
The benefits of covariate adjustment for adaptive multi-arm designs |
|
|
| Kim May Lee, David S. Robertson, Thomas Jaki, Richard Emsley |
|
| Statistical Methods in Medical Research. 2022; : 0962280222 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective |
|
|
| Elja Arjas, Dario Gasbarra |
|
| BMC Medical Research Methodology. 2022; 22(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Applying concepts from “rapid” and “agile” implementation to advance implementation research |
|
|
| Andrew Quanbeck, Rose Garza Hennessy, Linda Park |
|
| Implementation Science Communications. 2022; 3(1): 21 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Electronic Health Interventions for Patients With Breast Cancer: Systematic Review and Meta-Analyses |
|
|
| Anna C. Singleton, Rebecca Raeside, Karice K. Hyun, Stephanie R. Partridge, Gian Luca Di Tanna, Nashid Hafiz, Qiang Tu, Justin Tat-Ko, Stephanie Che Mun Sum, Kerry A. Sherman, Elisabeth Elder, Julie Redfern |
|
| Journal of Clinical Oncology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review |
|
|
| Dionysios Palermos, Theodoros N. Sergentanis, Maria Gavriatopoulou, Panagiotis Malandrakis, Theodora Psaltopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos |
|
| Journal of Clinical Medicine. 2022; 11(23): 7176 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Indian Pharmaceutical Industries Current Status and Togetherness to Overcome Speed Breakers in Term of Quality Issues to make India as a Global Pharma Destination |
|
|
| Vikas Rathee, Kapil Pihwal, Neelam Pawar, Sheikh Aamir, Mohammad S. Alam, Kavita Bahmani |
|
| Applied Drug Research, Clinical Trials and Regulatory Affairs. 2021; 8(1): 19 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Brain Organoids: Tiny Mirrors of Human Neurodevelopment and Neurological Disorders |
|
|
| Anuradha Yadav, Brashket Seth, Rajnish Kumar Chaturvedi |
|
| The Neuroscientist. 2021; 27(4): 388 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019: A review and meta-analytic approach |
|
|
| Brian Freed, Brian Williams, Xiaolu Situ, Victoria Landsman, Jeehyoung Kim, Alex Moroz, Heejung Bang, Jongbae J Park |
|
| Clinical Trials. 2021; 18(3): 361 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
RCTs and other clinical trial designs in Ayurveda: A review of challenges and opportunities |
|
|
| Pushya A. Gautama |
|
| Journal of Ayurveda and Integrative Medicine. 2021; 12(3): 556 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Challenges in Evaluating Safety and Efficacy in Drug Development for Rare Diseases: A Review for Pharmacists |
|
|
| Kanya K. Shah, Stephen Kogut, Angela Slitt |
|
| Journal of Pharmacy Practice. 2021; 34(3): 472 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Adaptive design implementation in confirmatory trials: methods, practical considerations and case studies |
|
|
| Qing Li, Jianchang Lin, Yunzhi Lin |
|
| Contemporary Clinical Trials. 2020; 98: 106096 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Including non-concurrent control patients in the analysis of platform trials: is it worth it? |
|
|
| Kim May Lee, James Wason |
|
| BMC Medical Research Methodology. 2020; 20(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Adaptive Design of Clinical Trials: A Sequential Learning Approach |
|
|
| Zhengli Wang, Stefanos Zenios |
|
| SSRN Electronic Journal. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
An investigation of the impact of futility analysis in publicly funded trials |
|
|
| Benjamin GO Sully,Steven A Julious,Jon Nicholl |
|
| Trials. 2014; 15(1): 61 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
How can attrition rates be reduced in cancer drug discovery? |
|
|
| Lucas Moreno,Andrew DJ Pearson |
|
| Expert Opinion on Drug Discovery. 2013; 8(4): 363 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine |
|
|
| Antman, E., Weiss, S., Loscalzo, J. |
|
| Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2012; 4(4): 367-383 |
|
| [Pubmed] [Google Scholar] |
|
| 20 |
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine |
|
|
| Elliott Antman,Scott Weiss,Joseph Loscalzo |
|
| Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2012; 4(4): 367 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Adaptive trial design: Its growing role in clinical research and implications for pharmacists |
|
|
| Cirulli, J., McMillian, W.D., Saba, M., Stenehjem, D. |
|
| American Journal of Health-System Pharmacy. 2011; 68(9): 807-813 |
|
| [Pubmed] [Google Scholar] |
|
| 22 |
Adaptive design - an innovative tool in drug development |
|
|
| Brahmachari, B., Bhatt, A. |
|
| Indian Journal of Medical Research. 2011; 133(3): 243-245 |
|
| [Pubmed] [Google Scholar] |
|
| 23 |
Implications of comparative effectiveness research for radiation oncology |
|
|
| Justin E. Bekelman,Anand Shah,Stephen M. Hahn |
|
| Practical Radiation Oncology. 2011; 1(2): 72 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
